CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.

To help children through cancer treatment, yoga therapy is offered at our Voorhees and King of Prussia Specialty Care Centers.

CHOP researchers have found that implementation science is underused in pediatric oncology and call for more research in this area to improve patient care.

Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.

Researchers have unlocked patterns to improve the diagnosis of the most common epigenetic childhood cancer disorder.

A cell and gene therapy expert, Grupp discussed progress in clinical care in the 50 years since the legislation was signed.

Parents of a precious child lost to cancer are determined to find a cure.

 CHOP’s annual Parkway Run & Walk, presented by Citadel, raised over $1.6 million to support childhood cancer research and care at Children’s Hospital of Philadelphia (CHOP)

CHOP researchers have developed a novel cancer therapy that targets proteins inside cancer cells that are essential for tumor growth and survival but have been historically impossible to reach.

To celebrate a long-standing relationship built on their mutual commitment to improve the care of pediatric patients within Saudi Arabia, Children’s Hospital of Philadelphia welcomed members of the Royal Embassy of Saudi Arabia.